K Bailey Freund Selected Research

Endothelial Growth Factors

5/2022	Characterisation of the vascular anterior surface of type 1 macular neovascularisation after anti-VEGF therapy.
5/2017	Optical coherence tomography angiography of type 3 neovascularisation in age-related macular degeneration after antiangiogenic therapy.
12/2016	Outcomes of intravitreal anti-VEGF therapy in eyes with both neovascular age-related macular degeneration and diabetic retinopathy.
3/2016	TYPE 2 (SUBRETINAL) NEOVASCULARIZATION IN AGE-RELATED MACULAR DEGENERATION ASSOCIATED WITH PURE RETICULAR PSEUDODRUSEN PHENOTYPE.
8/2015	Baseline Predictors for Good Versus Poor Visual Outcomes in the Treatment of Neovascular Age-Related Macular Degeneration With Intravitreal Anti-VEGF Therapy.
4/2012	Sustained increased intraocular pressure related to intravitreal antivascular endothelial growth factor therapy for neovascular age-related macular degeneration.
3/2011	Multimodal fundus imaging of pseudoxanthoma elasticum.
5/2010	Long-term outcomes of intravitreal antivascular endothelial growth factor therapy for the management of choroidal neovascularization in pseudoxanthoma elasticum.
11/2009	"Treat and extend" dosing of intravitreal antivascular endothelial growth factor therapy for type 3 neovascularization/retinal angiomatous proliferation.
11/2009	Retrospective review of the efficacy of topical bromfenac (0.09%) as an adjunctive therapy for patients with neovascular age-related macular degeneration.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

K Bailey Freund Research Topics

Disease

108	Macular Degeneration (Age-Related Maculopathy) 12/2022 - 02/2002
30	Choroidal Neovascularization 08/2020 - 02/2002
27	Atrophy 12/2022 - 01/2014
16	Polypoidal Choroidal Vasculopathy 11/2022 - 08/2002
16	Central Serous Chorioretinopathy 11/2022 - 10/2002
15	White Dot Syndromes 05/2022 - 04/2006
15	Hemorrhage 01/2021 - 01/2009
14	Macular Edema 01/2021 - 03/2006
12	Retinal Vein Occlusion 01/2022 - 03/2006
12	Ischemia 01/2021 - 10/2013
11	Multifocal Choroiditis 03/2022 - 10/2002
11	Geographic Atrophy 09/2021 - 04/2014
8	Fibrosis (Cirrhosis) 01/2022 - 01/2011
8	Vascular Diseases (Vascular Disease) 01/2022 - 04/2007
7	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2022 - 09/2006
6	Retinal Perforations 12/2022 - 05/2015
6	Myopia 11/2022 - 10/2006
6	Neoplasms (Cancer) 01/2022 - 01/2011
6	Edema (Dropsy) 11/2021 - 04/2006
6	Disease Progression 01/2020 - 09/2009
6	Pseudoxanthoma Elasticum (Gronblad Strandberg Syndrome) 01/2019 - 10/2005
5	Epiretinal Membrane (Epiretinal Membranes) 07/2021 - 03/2008
4	Retinal Detachment (Retinal Detachments) 11/2022 - 12/2017
4	Infarction (Infarctions) 07/2022 - 08/2005
4	Hamartoma 12/2021 - 01/2011
4	Inflammation (Inflammations) 07/2021 - 10/2009
4	Wounds and Injuries (Trauma) 03/2021 - 02/2015
3	Nevus (Nevi) 11/2022 - 01/2015
3	Vitelliform Macular Dystrophy 09/2021 - 01/2019
3	Toxoplasmosis 07/2021 - 01/2019
3	Gliosis 01/2021 - 01/2017
3	Retinal Hemorrhage 11/2020 - 01/2011
3	Cysts 08/2020 - 07/2015
3	Rupture 01/2020 - 02/2011
3	Retinal Diseases 01/2018 - 08/2015
3	Endophthalmitis (Ophthalmia) 12/2014 - 05/2008
2	Ganglion Cysts (Ganglion) 03/2022 - 01/2015
2	Chorioretinitis 07/2021 - 03/2019
2	Telangiectasis (Telangiectasia) 01/2021 - 09/2006
2	Retinal Vasculitis 10/2020 - 01/2020
2	Acute zonal occult outer retinopathy 03/2020 - 10/2013
2	Phlebitis 03/2020 - 01/2012
2	Choroidal Effusions 01/2019 - 12/2017
2	Hyperplasia 01/2019 - 07/2014
2	Uveitis 11/2018 - 04/2014
2	Melanoma (Melanoma, Malignant) 12/2017 - 11/2014
2	Retinoschisis (Retinoschisis, Juvenile) 12/2017 - 07/2014
2	Renal Insufficiency (Renal Failure) 11/2017 - 01/2014
2	Stargardt Disease 02/2015 - 10/2013
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 09/2014 - 10/2013
2	Angioid Streaks 05/2010 - 09/2007
2	Panuveitis 07/2008 - 10/2002
1	Spontaneous Remission 10/2022
1	Posterior Uveitis 03/2022
1	Immunoglobulin G4-Related Disease 03/2022
1	Cicatrix (Scar) 01/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Venous Insufficiency 01/2022
1	Stroke (Strokes) 01/2022
1	Arteritis 11/2021
1	Hypertrophy 05/2021

Drug/Important Bio-Agent (IBA)

125	Retinaldehyde (Retinal)IBA 12/2022 - 08/2002
41	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 03/2022 - 04/2007
33	Fluorescein (Funduscein)FDA LinkGeneric 11/2022 - 08/2002
21	Ranibizumab (Lucentis)FDA Link 08/2022 - 09/2007
16	Indocyanine Green (Cardio-Green)FDA LinkGeneric 11/2022 - 08/2002
16	Bevacizumab (Avastin)FDA Link 05/2021 - 03/2006
11	Endothelial Growth FactorsIBA 05/2022 - 09/2009
10	Retinal Pigments (Pigments, Visual)IBA 11/2022 - 01/2012
9	Verteporfin (Visudyne)FDA Link 11/2022 - 02/2002
8	LipidsIBA 12/2022 - 08/2002
7	afliberceptIBA 01/2022 - 09/2013
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2015
4	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2022 - 10/2002
4	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2022 - 10/2002
3	CholesterolIBA 03/2020 - 11/2015
3	Coloring Agents (Dyes)IBA 01/2019 - 08/2003
3	Complement Factor H (Factor H)IBA 12/2014 - 11/2008
3	Triamcinolone (Aristocort)FDA Link 06/2010 - 06/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 07/2021 - 12/2014
2	brolucizumabIBA 10/2020 - 01/2019
2	Fluconazole (Zonal)FDA LinkGeneric 07/2014 - 01/2014
2	anecortave acetateIBA 09/2006 - 09/2006
1	Biological ProductsIBA 05/2022
1	SDDSIBA 01/2022
1	HDL LipoproteinsIBA 01/2022
1	Angiogenesis InhibitorsIBA 11/2021
1	Prednisone (Sone)FDA LinkGeneric 11/2021
1	SteroidsIBA 07/2021

Therapy/Procedure

39	Therapeutics 05/2022 - 02/2002
23	Injections 01/2019 - 09/2007
18	Lasers (Laser) 03/2022 - 06/2012
12	Intravitreal Injections 03/2022 - 03/2006
11	Photochemotherapy (Photodynamic Therapy) 11/2021 - 02/2002
7	Traction 11/2022 - 03/2008
7	Aftercare (After-Treatment) 01/2020 - 07/2008
3	Drug Therapy (Chemotherapy) 01/2015 - 06/2013
2	Vitrectomy 07/2016 - 05/2015
2	Induced Hyperthermia (Thermotherapy) 11/2014 - 09/2005
1	Vitreoretinal Surgery 01/2022